Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | ACHE | P22303 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 4/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197898 | 0.90 | CYP3A4 (0.81) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL725269 | 0.87 | CYP3A4 (0.77) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL950536 | 0.85 | CYP3A4 (1.00) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL3469596 | 0.84 | CYP3A4 (0.72) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL23484417 | 0.81 | CYP3A4 (0.68) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL20561796 | 0.81 | CYP3A4 (0.68) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL20503232 | 0.81 | CYP3A4 (0.68) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| Orsellinic Acid, Ethyl Ester SCHEMBL1648471 | 0.81 | CYP3A4 (1.00) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL28196195 | 0.80 | GLO1 (0.70) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 | |
| SCHEMBL22799252 | 0.79 | CYP3A4 (0.66) | CYP3A4ACHEHPGDSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| CN-119156138-A | Vapor treatment of agricultural products | 阿比尔技术公司 | 2024-12-17 | — | — | CN | claimed |
| US-11903388-B2 | Lichen compounds that inhibit mycotoxin production | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2024-02-20 | — | — | US | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| EP-4090167-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | Apeel Technology, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| US-20220330565-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. | 2022-10-20 | — | — | US | claimed |
| WO-2022217089-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. (US) | 2022-10-13 | — | — | WO | claimed |
| US-20220104501-A1 | LICHEN COMPOUNDS THAT INHIBIT MYCOTOXIN PRODUCTION | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2022-04-07 | — | — | US | claimed |
| CN-101461828-A | Method for preparing extract of Usnea diffracta Vain | LANZHOU INST CHEM PHYSICS CAS (CN) | 2009-06-24 | — | — | CN | claimed |
| EP-0446925-B1 | Process for the preparation of beta-resorcylic acid derivatives | CONSORTIUM ELEKTROCHEM IND (DE) | 1995-06-21 | — | — | EP | claimed |
| JP-6206849-A | — | — | None | — | — | JP | disclosed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | SUMITOMO CHEMICAL CO (JP) | 2026-01-01 | — | — | US | disclosed |
| US-20250228811-A1 | Triester Compounds And Methods Of Use Thereof | LIFEMINE THERAPEUTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| WO-2003076424-A1 | MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS | EISAI CO. LTD. (JP) | 2003-09-18 | — | — | WO | disclosed |
| EP-1300403-A1 | Process for the manufacture of hypoxyxylerone derivatives | Aventis Pharma S.A. (FR) | 2003-04-09 | — | — | EP | disclosed |
| EP-0446925-B1 | Process for the preparation of beta-resorcylic acid derivatives | CONSORTIUM ELEKTROCHEM IND (DE) | 1995-06-21 | — | — | EP | disclosed |
| JP-H06206849-A | PREPARATION OF BETA-RESORCYCLIC ACID DERIVATIVE | CONSORTIUM ELEKTROCHEM IND GMBH | 1994-07-26 | — | — | JP | disclosed |
| US-5171878-A | Reacting a diketene with a beta-keto ester in presence of alkaline earth compound; perfumes | CONSORTIUM FOR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1992-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11903388-B2 | Lichen compounds that inhibit mycotoxin production | LSS, ERG28, LTA | CYP3A4 3038/4885ACHE 2918/4885HPGD 866/4885 |
| US-20250228811-A1 | Triester Compounds And Methods Of Use Thereof | CYP46A1, CYP17A1, CYP27A1 | CYP3A4 104/4885ACHE 1179/4885HPGD 815/4885 |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | CYP3A4 3888/4885ACHE 840/4885HPGD 1149/4885 |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | CCR1, H1-3, CCR3 | CYP3A4 3394/4885ACHE 3399/4885HPGD 2370/4885 |
| US-20220104501-A1 | LICHEN COMPOUNDS THAT INHIBIT MYCOTOXIN PRODUCTION | LSS, ERG28, LTA | CYP3A4 3038/4885ACHE 2918/4885HPGD 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.